These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 11032901
1. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A. J Neurochem; 2000 Nov; 75(5):2113-22. PubMed ID: 11032901 [Abstract] [Full Text] [Related]
2. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice. Montañez S, Munn JL, Owens WA, Horton RE, Daws LC. Neurochem Int; 2014 Jul; 73():127-31. PubMed ID: 24246466 [Abstract] [Full Text] [Related]
3. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol. Dawson LA, Nguyen HQ. Neuropharmacology; 2000 Apr 03; 39(6):1044-52. PubMed ID: 10727715 [Abstract] [Full Text] [Related]
4. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice. De Groote L, Olivier B, Westenberg HG. Eur J Pharmacol; 2002 Mar 29; 439(1-3):93-100. PubMed ID: 11937097 [Abstract] [Full Text] [Related]
5. 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus. Daws LC, Gerhardt GA, Frazer A. Neurosci Lett; 1999 May 14; 266(3):165-8. PubMed ID: 10465699 [Abstract] [Full Text] [Related]
6. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. Knobelman DA, Hen R, Lucki I. J Pharmacol Exp Ther; 2001 Sep 14; 298(3):1083-91. PubMed ID: 11504805 [Abstract] [Full Text] [Related]
7. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe. Dong J, De Montigny C, Blier P. Synapse; 1999 Dec 15; 34(4):277-89. PubMed ID: 10529722 [Abstract] [Full Text] [Related]
8. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. de Groote L, Olivier B, Westenberg HG. Psychopharmacology (Berl); 2002 Aug 15; 162(4):419-24. PubMed ID: 12172696 [Abstract] [Full Text] [Related]
9. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine. Béïque JC, Blier P, de Montigny C, Debonnel G. Neuropsychopharmacology; 2000 Sep 15; 23(3):294-306. PubMed ID: 10942853 [Abstract] [Full Text] [Related]
10. Serotonin transporter function in vivo: assessment by chronoamperometry. Frazer A, Daws LC. Ann N Y Acad Sci; 1998 Dec 15; 861():217-29. PubMed ID: 9928259 [Abstract] [Full Text] [Related]
11. Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. de Groote L, Klompmakers AA, Olivier B, Westenberg HG. Psychopharmacology (Berl); 2003 May 15; 167(2):153-8. PubMed ID: 12644890 [Abstract] [Full Text] [Related]
12. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo. Yoshitake T, Yoshitake S, Yamaguchi M, Ogren SO, Kehr J. Neuropharmacology; 2003 Feb 15; 44(2):206-13. PubMed ID: 12623219 [Abstract] [Full Text] [Related]
13. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study. Míguez JM, Paz-Valiñas L, Míguez I, Aldegunde M. Naunyn Schmiedebergs Arch Pharmacol; 2002 May 15; 365(5):378-87. PubMed ID: 12012024 [Abstract] [Full Text] [Related]
15. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP. Eur J Neurosci; 2000 Jul 15; 12(7):2299-310. PubMed ID: 10947809 [Abstract] [Full Text] [Related]
16. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. Knobelman DA, Hen R, Blendy JA, Lucki I. J Pharmacol Exp Ther; 2001 Sep 15; 298(3):1092-100. PubMed ID: 11504806 [Abstract] [Full Text] [Related]
17. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F. Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep 15; 358(3):315-22. PubMed ID: 9774218 [Abstract] [Full Text] [Related]
18. Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. Daws LC, Montañez S, Owens WA, Gould GG, Frazer A, Toney GM, Gerhardt GA. J Neurosci Methods; 2005 Apr 15; 143(1):49-62. PubMed ID: 15763136 [Abstract] [Full Text] [Related]
20. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram. Cremers TI, de Boer P, Liao Y, Bosker FJ, den Boer JA, Westerink BH, Wikström HV. Eur J Pharmacol; 2000 May 26; 397(1):63-74. PubMed ID: 10844100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]